Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The Association of an Alpha-2 Adrenergic Receptor Agonist and Mortality in Patients With COVID-19

Frontiers in Medicine(2022)10.3389/fmed.2021.797647Source: DataRank Database

The Association of an Alpha-2 Adrenergic Receptor Agonist and Mortality in Patients With COVID-19 is a research paper published in Frontiers in Medicine (2022). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access10 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 1.53)OA: goldTopics (23)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Mona Vashi,Ekta Kishen,Louis Fogg ORCID,Markus A. Wimmer ORCID,R.A. Balk ORCID

Live enrichment

PubMed:35059419 OpenAlex:https://openalex.org/W4206394614

National Institutes of Health

Grant: 1T32AR073157-01A1

Post-Doctoral Training in Joint Health

National Institutes of Health

Grant: 5UL1TR002389-04

ITM 2.0: Advancing Translational Science in Metropolitan Chicago

NIAMS NIH HHS

Grant: T32 AR073157

FWCI

1.53

Citation Percentile

0.8%

Citation Trend

2022

2023

2024

goldLicense: cc-by

journalhttps://doi.org/10.3389/fmed.2021.797647

publisherhttps://doi.org/10.3389/fmed.2021.797647

publisherhttps://www.frontiersin.org/articles/10.3389/fmed.2021.797647/full

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35059419

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8764306

Fields of Study

Intensive Care Unit Cognitive DisordersAnesthesia and Sedative AgentsLong-Term Effects of COVID-1903 medical and health sciences0302 clinical medicine

Keywords

MedicineDexmedetomidineAgonistIntubationCohortMechanical ventilationSedationRetrospective cohort studyInternal medicineProportional hazards modelAnesthesiaReceptorMedicine (General)R5-920coronavirus disease 2019 (COVID-19)severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)mortalityalpha-2 adrenergic receptor agonist

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being